Bacillus calmette-guerin substrain tice live antigen Completed Phase 1 Trials for Transitional Cell Carcinoma of the Bladder Treatment

Indications	Status	Purpose	Phase
DBCOND0028556 (Transitional Cell Carcinoma of the Bladder)	Completed	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT01878188	Pilot Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder Carcinoma	BCG vaccine (DB12768) Bacillus calmette-guerin substrain tice live antigen (DB10343) Inodiftagene vixteplasmid (DB16017)